Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report) shares crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $1.02 and traded as high as $5.34. Mesoblast shares last traded at $5.30, with a volume of 600 shares.
Mesoblast Stock Up 143.1 %
The company’s fifty day simple moving average is $1.49 and its 200-day simple moving average is $1.02.
About Mesoblast
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
Further Reading
- Five stocks we like better than Mesoblast
- What is the Euro STOXX 50 Index?
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- How to Invest in Small Cap Stocks
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Delta Can Fly to New Highs in 2025; Here’s Why
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
